Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc.（ARNA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
arna · 股价预测 · 23 位分析师（近3月）· FMP · 更新于 2023年12月4日
分析师评级与共识
基于过去 3 个月内 23 位华尔街分析师
Buy
23 位分析师
共识
评级分布
12 个月目标价
High
$100
Consensus
$94.00
-6.0% upside
Low
$90.00
Median: $92 · Last Close: $99.99
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$94.00
-6.0% upside
High Target
$100
0.0%
Low Target
$90
-10.0%
Current Price
$99.99
as of today
Based on analyst price targets, the ARNA stock price prediction for the next 12 months ranges from $90 to $100. The consensus ARNA price forecast of $94.00 implies -6.0% upside from the current price of $99.99.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $101.36 | ↑ 1.37% |
1-day model range: $101.14–$101.58. Peak: $101.58 (+1.37%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ARNA · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-02-09 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2021-12-21 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2021-12-14 | RBC Capital | Downgrade ↓ | Outperform→Perform |
| 2021-12-14 | SVB Leerink | Downgrade ↓ | Outperform→Perform |
| 2021-12-14 | JMP Securities | Downgrade ↓ | Market Outperform→Perform |
| 2021-12-14 | Citigroup | Downgrade ↓ | Buy→Neutral |
| 2021-08-10 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2021-08-06 | Credit Suisse | Maintains | Outperform→Outperform |
| 2021-05-18 | Goldman Sachs | Maintains | Buy→Buy |
| 2021-05-07 | SVB Leerink | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Arena Pharmaceuticals, Inc. (ARNA) stock. Of the recent 64 rating actions, 4 were upgrades and 7 were downgrades. 23 analysts currently cover ARNA.
分析师推荐趋势
ARNA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
—
Revenue Next Year
—
EPS This Year
—
EPS Next Year
—
EPS ForecastReported vs Estimated
Analysts forecast ARNA EPS of $— for the current fiscal year, based on estimates from 0 analysts. The ARNA revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ARNA 股价预测由两类独立数据源支撑：来自 23 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ARNA 的共识目标价为 $94.00（-6.0% 上行空间），分析师共识为 Buy。
ARNA 的短期预测（明日）为 $101.36（+1.37%）。
Arena Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 ARNA。ARNA 在 2027 年的整体展望偏积极，在覆盖分析师中约 61% 对应 Buy 共识。
常见问题
ARNA 预测 · 8 个问题根据 23 位华尔街分析师，ARNA 的 12 个月平均目标价为 $94.00，最高 $100.00、最低 $90.00。若有图表，中位目标价可在上方查看。相对当前价 $99.99，隐含约 -6.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.